Normal people have circulating T-cells that have... - MPN Voice

MPN Voice

10,437 members14,387 posts

Normal people have circulating T-cells that have recognized the CALR mutation as an invader to the immune system and destroyed it

clubdino profile image
17 Replies

This study has demonstrated that normal people have been exposed to the CALR mutation but their immune system recognized the enemy and destroyed it.

The study was first done on Jak2 positive people since patients with double mutations (Jak2 and CALR positive) are very rare. They noticed that the Jak2 positive people had circulating T-cells that recognized the CALR mutation and destroyed it. From there the scientists studied T-cells in the normal population and noticed they also had circulating T-cells that had a memory in regards to the CALR mutation and their immune systems recognized it as an invader.

For some reason our immune system didn't recognize the troublemaker and said, "take your shoes off and stay awhile." This research was done by the same group who are trying to develop a CALR vaccine. Interesting stuff.

ncbi.nlm.nih.gov/pmc/articl...

Written by
clubdino profile image
clubdino
To view profiles and participate in discussions please or .
17 Replies
mhos61 profile image
mhos61

Thanks, will have a look over the weekend. All very interesting.

welshhuw profile image
welshhuw

Thank you for posting this information, I have been following the CALR phase I vaccine study that is currently underway in Denmark, hopefully there will be some positive results when the study concludes.

clubdino profile image
clubdino in reply to welshhuw

It's very interesting indeed. I always assumed the CALR mutation was only found in people with MPNs. I did not know that healthy people had been exposed to CALR but their immune system took appropriate action. Even people who are JAK2 positive fought off the CALR mutation.

welshhuw profile image
welshhuw in reply to clubdino

I also wasn't aware until I came across this abstract about 6 months ago.(ncbi.nlm.nih.gov/pubmed/286... Then doing a bit more research I also came across the CALR phase I vaccine study currently being performed at the Harlev hospital in Denmark (Primary end date Feb 2020 but not sure when they will report). If the study had been performed in the UK I would have been very tempted to volunteer. The in-vitro data looks very compelling, particularly considering that the T-cells were able to recognise several epitopes and were cytotoxic to autologous CALRmut cells. If the research group can develop a vaccine to stimulate a sufficiently strong specific immune response, things could get very exciting. Fingers crossed !

clubdino profile image
clubdino in reply to welshhuw

I'd love to see a bunch of dead degranulated CALRmut cells laying all over the place and then their tiny bodies are phagocytized by the biggest, fattest, hungriest macrophage that ever existed. We'll call him Fat Albert. It would make my day.

But seriously, wouldn't it be awesome to take part in the clinical trial and have a place in history in the destruction of the CALR mutation. I have high hopes for this one.

welshhuw profile image
welshhuw in reply to clubdino

hahaha !..... what a wonderful description ! Here's to Fat Albert, the hungriest CALRmut macrophage ever to have existed !

socrates_8 profile image
socrates_8 in reply to clubdino

Hey Clubdino...

Yes, I agree quite an interesting finding indeed. I shall watch this one continue to unfold with an increased level of interest.

Thank you for the Post

Steven

(Sydney)

clubdino profile image
clubdino in reply to socrates_8

It could be the beginning of the end. 💥💥💥💥

socrates_8 profile image
socrates_8 in reply to clubdino

Yes, I agree that there is every reason to be a tad optimistic but still a ways to go yet... ;-)

Cheers

Steven

welshhuw profile image
welshhuw in reply to clubdino

I suspect you may already have the link to the CALR vaccine study but just in case

clinicaltrials.gov/ct2/show...

clubdino profile image
clubdino in reply to welshhuw

I was actually looking at it right when you sent it. Where is the study taking place? In Denmark or the US?

clubdino profile image
clubdino in reply to clubdino

Ah, nevermind, it looks like it's Denmark.

welshhuw profile image
welshhuw in reply to clubdino

At the Herlev Hospital in Denmark, it's a small phase 1 study, recruitment is closed, so I'm assuming they already have the numbers. This group is very active in researching the immunogenicity aspects of MPNs, I believe they are also looking into the feasibility of a JAK2 vaccine but it seems much more challenging from an immunological perspective.

clubdino profile image
clubdino in reply to welshhuw

We are lucky to have scientists that are interested in our disease. I used to be a veterinary oncology technician and I was tasked to give the melanoma vaccines to the dogs. Melanoma in dogs is a very aggressive and ugly cancer...it almost always grows in the back of the mouth (and smells like the bog of eternal stench) and it usually metastasizes to the lungs very rapidly. I can't say that the vaccine was super effective so I hope the CALR vaccine pulls through and delivers. Melanoma moves much more rapidly then ET so we are lucky in that aspect. I think there is a lymphoma vaccine too.

The T-cells do not rid the body of the genetic mutation but only the cells produced as a result of the mutation.

clubdino profile image
clubdino in reply to

As long as in the future my ADHD T-cells can develop a memory and recognize the cancer cells as unwanted houseguests I will take what I can get.

Wyebird profile image
Wyebird

Amazing I look forward to reading it. Thank you so much

You may also like...

Immunotherapy, early research for Jak2

engineering disease-recognizing molecules on immune cells — T-cell receptors, or TCRs — to...

Sensitivity of driver mutation tests for CALR and MPL - not sure if I'm confident

3 driver mutations came back negative. Spoke with my MPN specialist about the driver mutation tests...

Triple Negative Question

Interferon targets the JAK2 cells & normal cells correct? Would interferon just target the cells in...

ET and blast cells - new here and overwhelmed

has just been diagnosed with ET (negative for JAK2, CALR, MPL and BCR ABL) and we are waiting on...

Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia

demonstrated that JAK2 mutated endothelial cells promoted leukocyte adhesion and rolling via...